NCT02029729View on ClinicalTrials.gov

RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER

PHASE1CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 1, 2015

Study Completion Date

October 1, 2015

Conditions

Metastatic or Incurable Non-small Cell Lung CancerRelapsed, Refractory Melanoma

Interventions

DRUG

omaveloxolone

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center (NSCLC), Tampa

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

Biogen

INDUSTRY